newsfilter
← Latest News
GlobeNewswire·

BioNTech Announces Second Quarter 2026 Financial Results and Corporate Update

Guido Oelkers, Ph.D., appointed to BioNTech Management Board as Chief Executive Officer, taking office by February 1, 2027, at the latestAdvanced diversified pipeline now with 14 ongoing pivotal clinical trials and more